mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
0.004 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
Compound 7d-cis |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
-0.098 |
0.005 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
0.16 |
0.005 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.005 |